Bo Lak (002760) - Total Liabilities

Latest as of December 2025: ₩10.51 Billion KRW ≈ $7.12 Million USD

Based on the latest financial reports, Bo Lak (002760) has total liabilities worth ₩10.51 Billion KRW (≈ $7.12 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 002760 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Bo Lak - Total Liabilities Trend (2013–2025)

This chart illustrates how Bo Lak's total liabilities have evolved over time, based on quarterly financial data. See Bo Lak free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Bo Lak Competitors by Total Liabilities

The table below lists competitors of Bo Lak ranked by their total liabilities.

Company Country Total Liabilities
Angkor Resources Corp
V:ANK
Canada CA$5.86 Million
Chia Ta World Co Ltd
TW:2033
Taiwan NT$171.71 Million
Wooshin System
KO:017370
Korea ₩240.80 Billion
Hongli Group Inc. Ordinary Shares
NASDAQ:HLP
USA $14.36 Million
Hung Chou Fiber Ind Co Ltd
TW:1413
Taiwan NT$1.50 Billion
Far East Fame Line DDB Public Company Limited
BK:FE
Thailand ฿213.80 Million
Career Point Limited
NSE:CAREERP
India Rs932.47 Million
Koge Micro Tech Co Ltd
TWO:4568
Taiwan NT$576.52 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Bo Lak's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bo Lak (002760) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.51 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bo Lak's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bo Lak (2013–2025)

The table below shows the annual total liabilities of Bo Lak from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 ₩10.51 Billion
≈ $7.12 Million
-16.79%
2024-12-31 ₩12.63 Billion
≈ $8.56 Million
+38.06%
2023-12-31 ₩9.15 Billion
≈ $6.20 Million
-26.97%
2022-12-31 ₩12.53 Billion
≈ $8.49 Million
+16.28%
2021-12-31 ₩10.77 Billion
≈ $7.30 Million
+6.60%
2020-12-31 ₩10.11 Billion
≈ $6.85 Million
-13.39%
2019-12-31 ₩11.67 Billion
≈ $7.91 Million
+22.17%
2018-12-31 ₩9.55 Billion
≈ $6.47 Million
+10.95%
2017-12-31 ₩8.61 Billion
≈ $5.83 Million
-17.14%
2016-12-31 ₩10.39 Billion
≈ $7.04 Million
+9.15%
2015-12-31 ₩9.52 Billion
≈ $6.45 Million
-8.14%
2014-12-31 ₩10.36 Billion
≈ $7.02 Million
-0.71%
2013-12-31 ₩10.44 Billion
≈ $7.07 Million
--

About Bo Lak

KO:002760 Korea Specialty Chemicals
Market Cap
$39.38 Million
₩58.10 Billion KRW
Market Cap Rank
#22756 Global
#1450 in Korea
Share Price
₩970.00
Change (1 day)
-0.10%
52-Week Range
₩837.00 - ₩1323.00
All Time High
₩4129.14
About

Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docet… Read more